ArticleHeliyon2025
Alternative prioritization for mitigating competition-related issues in Tanzania sugar industry using an integrated multi-criteria decision-making approach.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- JAK/STAT3 axis in breast cancer: opportunities for intervention with natural phytochemical-based nanotherapeutics.Medical oncology (Northwood, London, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Professionals and policymakers often encounter challenges in selecting and ranking effective solutions to address competition-related issues in various industries including sugar industry. Despite extensive research in this area, the Tanzanian context, significantly impacted by these challenges, has not received sufficient attention. Thus, this study aims to fill this gap by identifying and prioritizing these issues. It proposes four strategies and establishes five criteria for prioritization. To achieve this, the study introduces an integrated methodology to assess criteria weights and rank strategies based on these weighted criteria. The FullEX technique is applied to assess the criteria weights, while the AROMAN (Alternative Ranking Order Method Accounting for Two-Step Normalization) method is used to rank the alternatives. The study validates this methodology through a sensitivity and comparative analyses, which identifies the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.